Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kengo, Umehara"'
Autor:
Kengo Umehara, Kaori Yama, Nozomi Koike, Shintarou Takayama, Azusa Wakamoto, Tae Hatuyama, Michiya Kobayashi, Hideki Sato
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-11 (2020)
Abstract Background Pemetrexed (PEM) is administered over a long term to patients with non-squamous cell lung cancer as a maintenance therapy after platinum combination induction chemotherapy. Although decreased renal function owing to long-term PEM
Externí odkaz:
https://doaj.org/article/9d62890c3b264ab6b1e4d2a2c68c8e4c
Autor:
Kengo Umehara, Kaori Yama, Keisuke Goto, Azusa Wakamoto, Tae Hatsuyama, Osamu Honjo, Toyohiro Saikai, Akihisa Fujita, Hideki Sato
Publikováno v:
Cancer Control, Vol 28 (2021)
Introduction: Corticosteroids are used to treat immune-related adverse events (irAEs) associated with nivolumab. However, patients with non-small-cell lung cancer who are administered corticosteroids before the initiation of nivolumab treatment are c
Externí odkaz:
https://doaj.org/article/ecec087538944c1ea8719ec7d92f55e7
Autor:
Keisuke Kagami, Nobuhisa Ishiguro, Sumio Iwasaki, Takayuki Usami, Tatsuya Fukumoto, Kasumi Hayasaka, Reiko Oyamada, Tsubasa Watanabe, Sho Nakakubo, Yusuke Niinuma, Takashi Hagino, Yoshifumi Abe, Ikuya Fujimoto, Hideki Maekawa, Ryo Fujibayashi, Satoshi Fuke, Kuniko Asahi, Shuichi Ota, Tatsuya Nagakura, Toshinari Okubo, Hideomi Asanuma, Toshihiro Ito, Sho Okano, Erika Komatsu, Kota Sasaki, Kei Hashimoto, Kazutoshi Washiya, Yumiko Kato, Katsunori Kusumi, Yasufumi Asai, Yuichi Saito, Yoshiyuki Sakai, Minoru Sakurada, Yuji Sakimoto, Yukari Ichikawa, Takahiro Kinebuchi, Dai Kondo, Syuhei Kanno, Minoru Kobayashi, Kagami Hirabayashi, Shinako Saitou, Katsuhiko Saito, Yuuki Ebina, Yuusuke Koshizaki, Makoto Chiba, Atsushi Yasuda, Toshiya Sato, Atsuo Togashi, Takashi Abe, Takahiro Fujita, Kengo Umehara, Masaru Amishima, Nobuo Murakami, Tetsuya Yagi, Shuhei Fujimoto, Taichi Tajima, Mitsuru Sugawara, Yoh Takekuma
Publikováno v:
American Journal of Infection Control. 51:163-171
The Japan Surveillance for Infection Prevention and Healthcare Epidemiology (J-SIPHE) system aggregates information related to antimicrobial resistance (AMR) measures in participating medical institutions nationwide and is intended to be used for pro
Publikováno v:
Journal of Biophysical Chemistry. 14:67-78
Autor:
SHINYA TAKADA, YOSHIHIRO HOSOKAWA, KENGO UMEHARA, YUTA KIMURA, YUTA FUKAI, KARIN SHIKISHIMA, MITSUGU YAMAMOTO, HIDEKI MAEDA, NOBUMOTO TOMIOKA, KENICHI WATANABE, HIROKAZU HASHISHITA
Publikováno v:
In Vivo; Jan/Feb2024, Vol. 38 Issue 1, p500-505, 6p
Serum Albumin Affects the Time-to-treatment Failure of Alectinib: A Multicenter Retrospective Study.
Autor:
KENGO UMEHARA, KAORI YAMA, KEISUKE GOTO, TAKANOBU HOSHI, TOMOAKI HATAKEYAMA, MARIKO ISAJI, SHINYA TAKADA, KAYO YAMAGISHI, KOZO MINO, HIDEKI SATO
Publikováno v:
In Vivo; Sep/Oct2023, Vol. 37 Issue 5, p2260-2267, 8p
Autor:
Shinya, Takada, Hidetaka, Murooka, Kanae, Tahatsu, Maki, Yanase, Kengo, Umehara, Hirokazu, Hashishita, Harabayashi, Toru, Maruyama, Satoru, Tamotsu, Sagawa, Koshi, Fujikawa, Hideki, Sato, Kozo, Mino
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 23:695-701
Neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR) ratios can indicate poor disease prognosis and are inflammation markers. We investigated the role of NLR and PLR as effective predictive markers of immune-related adverse event (irAE) on
Autor:
Takeshi, Chiba, Haruki, Ujiie, Yukiko, Yaegashi, Kengo, Umehara, Shinya, Takada, Koichi, Otaki, Ken-Ichi, Sako, Yuta, Nakamaru, Tomoji, Meada, Kenzo, Kudo, Yoshikazu, Tasaki, Hideki, Sato
Publikováno v:
Biomedical Reports. 17
This study aimed to investigate whether renin-angiotensin system inhibitors (RAS-I) have an advantage over calcium channel blockers (CCB) for suppression of proteinuria in hypertensive patients with gastric cancer receiving ramucirumab (RAM) treatmen
Autor:
Kaori Yama, Hideki Sato, Azusa Wakamoto, Michiya Kobayashi, Tae Hatuyama, Kengo Umehara, Nozomi Koike, Shintarou Takayama
Publikováno v:
Renal Replacement Therapy, Vol 6, Iss 1, Pp 1-11 (2020)
Background Pemetrexed (PEM) is administered over a long term to patients with non-squamous cell lung cancer as a maintenance therapy after platinum combination induction chemotherapy. Although decreased renal function owing to long-term PEM exposure
Autor:
Tae Hatsuyama, Azusa Wakamoto, Keisuke Goto, Toyohiro Saikai, Kaori Yama, Kengo Umehara, Hideki Sato, Osamu Honjo, Akihisa Fujita
Publikováno v:
Cancer Control, Vol 28 (2021)
Cancer Control : Journal of the Moffitt Cancer Center
Cancer Control : Journal of the Moffitt Cancer Center
Introduction: Corticosteroids are used to treat immune-related adverse events (irAEs) associated with nivolumab. However, patients with non-small-cell lung cancer who are administered corticosteroids before the initiation of nivolumab treatment are c